Benjamin T. Dake - Officer Title: President, Chief Operating Officer and Secretary at Aerovate Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Officer Title: President, Chief Operating Officer and Secretary
Stock Symbol
AVTE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Benjamin T. Dake - trading volume in the past year for Aerovate Therapeutics, Inc.

Holdings reported by Benjamin T. Dake for Aerovate Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 14.3K $24.8K $1.74 Aug 1, 2024 Direct
Stock Option (Right to Buy) 0 $0 $16.37 Aug 1, 2024 Direct Common Stock

Transactions reported by Benjamin T. Dake for Aerovate Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.